The FUTURE-AI initiative at the IEEE BHI-BSN Conference 2022 in Ioannina

Published on: August 2, 2022
Categories: News

The ProCAncer-I Consortium together with the other AI4HI funded projects are organising a workshop with the title “Developing open, standard-based, interoperable Cancer Imaging Repositories in Europe: Issues, Experiences and Challenges” within the IEEE BHI-BHS Conference in Ioannina and is inviting every interested stakeholder to participate.

The IEEE-EMBS BHI 2022 will be co-organized with IEEE-EMBS BSN 2022 and will take place in Ioannina, Greece, from 27-30 September 2022. It will provide a unique forum to showcase enabling technologies of devices and sensors, hardware and software systems, predictive models, databases, and big data analytics and machine learning that optimize the acquisition, transmission, processing, monitoring, storage, retrieval, analysis, visualization and interpretation of vast volumes of multi-modal biomedical data, as well as related social, behavior, environmental, and geographical data.

The IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI) and the IEEE International Conference on Wearable and Implantable Body Sensor Networks (BSN) are sponsored by the IEEE Engineering in Medicine and Biology Society (IEEE-EMBS) on informatics and computing in healthcare and life sciences.

Check out the program here

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!